Skip to main content

Status Epilepticus

  • Chapter
  • First Online:
  • 91k Accesses

Abstract

Status epilepticus is a neurological emergency and immediate recognition is important to be able to control it before deleterious neuronal and systemic effects occur. The aims of this chapter are to aid the clinician in detecting status epilepticus, determining the emergent diagnostic tests and providing information on the administration of appropriate therapy. This chapter describes the clinical features of both convulsive and non-convulsive status epilepticus along with novel treatment options and controversies in management.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Brophy G, Bell R, Claassen J, Alldredge B, Bleck T, Glauser T et al. Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.

    Google Scholar 

  2. Lowenstein DH, Bleck T, Macdonald R. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(i):120–2.

    Article  CAS  PubMed  Google Scholar 

  3. Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348–55.

    Article  CAS  PubMed  Google Scholar 

  4. Hirsch L, Gaspard N. Status epilepticus. Continuum. 2013;19(3):767–94.

    PubMed  Google Scholar 

  5. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.

    Article  CAS  PubMed  Google Scholar 

  6. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249(11):1452–4.

    Article  CAS  PubMed  Google Scholar 

  7. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8.

    Article  CAS  PubMed  Google Scholar 

  8. Alldredge B, Gelb A, Isaacs SM, Corry M, Allen F, Urich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631–7.

    Article  CAS  PubMed  Google Scholar 

  9. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y et al; NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012; 366(7):591–600.

    Google Scholar 

  10. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16(6):527–32.

    Article  PubMed  Google Scholar 

  11. Kellinghaus C, Berning S, Stögbauer F. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand. 2014;129(5):294–9.

    Article  CAS  PubMed  Google Scholar 

  12. Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314–28.

    Article  PubMed  Google Scholar 

  13. Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med. 1993;22:1337–48.

    Article  CAS  PubMed  Google Scholar 

  14. Bleck T. Advances in the management of refractory status epilepticus. Crit Care Med. 1993;21:955–7.

    Article  CAS  PubMed  Google Scholar 

  15. Hanley D, Kross J. Use of Midazolam in the treatment of refractory status epilepticus. Clin Ther. 1998;20:1093–105.

    Article  CAS  PubMed  Google Scholar 

  16. Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol. Epilepsia. 1998;39:18–26.

    Article  CAS  PubMed  Google Scholar 

  17. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors and impact on outcome. Arch Neurol. 2002;59:205–10.

    Article  PubMed  Google Scholar 

  18. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–18.

    Article  PubMed  Google Scholar 

  19. Prasad A, Worrall B, Bertram E, Bleck T. Propofol and Midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001;42(3):380–6.

    Google Scholar 

  20. Claassen J, Hirsch L, Emerson R, Mayer S. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146–53.

    Article  CAS  PubMed  Google Scholar 

  21. Huff JS, Melnick E, TOmaszewski C, Thiessen M, Jagoda A, Fesmire F. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med. 2014;63:437–47.

    Article  PubMed  Google Scholar 

  22. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698–702.

    Article  PubMed  Google Scholar 

  23. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents: isoflurane and desflurane. Arch Neurol. 2004;61(8):1254–9.

    Article  PubMed  Google Scholar 

  24. Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist. 2005;11(6):348–61. Review.

    Article  PubMed  Google Scholar 

  25. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999;40 Suppl 1:S59–63; discussion S64–6.

    Google Scholar 

  26. Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology. 2003;61(8):1066–73.

    Article  PubMed  Google Scholar 

  27. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743–8.

    Article  CAS  PubMed  Google Scholar 

  28. Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54 Suppl 6:28–9.

    Google Scholar 

  29. Kaplan PW. Nonconvulsive status epilepticus. Neurology. 2003;61(8):1035–6.

    Article  PubMed  Google Scholar 

  30. Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49 Suppl 9:63–73.

    Google Scholar 

  31. Maganti R, Gerber P, Drees C, Chung S. Nonconvulsive status epilepticus. Epilepsy Behav. 2008;12(4):572–86.

    Article  PubMed  Google Scholar 

  32. Caraballo RH, Vining E. Ketogenic diet. HandbClin Neurol. 2012;108:783–93.

    Google Scholar 

  33. Thakur K, Probasco J, Hocker S, Roehl K, Henry B, Kossoff E, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82:665–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refracotyr status epilepticus. Neurocrit Care. 2008;9:189–97.

    Article  CAS  PubMed  Google Scholar 

  35. Kamel H, Cornes SB, Hegde M, Hall SE, Josephson SA. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care. 2010;12:204–10.

    Article  PubMed  Google Scholar 

  36. Broomall E, Natale JE, Grimason M, Goldstein J, Smith CM, Chang C, et al. Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann Neurol. 2014;76(6):911–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hocker S. Systemic complications of status epilepticus- an update. Epilepsy & Behavior. 2015;49:83–7.

    Article  Google Scholar 

  38. Wijdicks E. The multifaceted care of status epilepticus. Epilepsia. 2013;54 Suppl 6:61–3.

    Article  PubMed  Google Scholar 

  39. Belcour D, et al. Prevalence and risk factors of stress cardiomyopathy after convulsive status epilepticus in ICU patients. Crit Care Med. 2015;43(10):2164–70.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jharna N. Shah .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Shah, J.N., Luis, C.O.V.S. (2017). Status Epilepticus. In: Hyzy, R. (eds) Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-43341-7_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43341-7_38

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43339-4

  • Online ISBN: 978-3-319-43341-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics